APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial
November 30th, 2020
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN to Present at Imperial Capital 2020
November 27th, 2020
Applied DNA Significantly Expands Addressable Market for Linea™ COVID-19 Assay Kit via Successful Amendment to FDA EUA
November 25th, 2020
Applied DNA Secures Blanket Purchase Order for 10,000 Linea™ COVID-19 Tests
November 12th, 2020
Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
November 2nd, 2020
Applied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea™ COVID-19 Assay Kits Through Expanded Use of Robotic Automation
October 30th, 2020
Applied DNA Secures $1.0+ Million in COVID-19 Surveillance Testing Annualized Revenue
October 12th, 2020
Applied DNA Announces Repayment of Secured Convertible Notes
October 8th, 2020
APDN to Supply SBUH with COVID-19 Assay Kit
September 29th, 2020